Investigator
University Of Florence
Novel NMR-Based Approach to Reveal the ‘Metabolic Fingerprint’ of Cytotoxic Gold Drugs in Cancer Cells
A combination of pathway enrichment and metabolite clustering analysis is used to interpret untargeted
Comparative NMR metabolomics of the responses of A2780 human ovarian cancer cells to clinically established Pt-based drugs
A systematic and comparative 1H NMR metabolomics study is carried out to analyse the response of A2780 cancer cells to clinically established Pt drugs. The observed changes are referred to specific alterations of cellular processes.